Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 28 | 38 | 1,805 | 3,287 |
| Cost of Goods | N/A | 10 | 21 | 947 | 1,443 |
| Gross Profit | N/A | 19 | 17 | 857 | 1,845 |
| Operating Expenses | 2 | 1,033 | 2,067 | 2,515 | 3,008 |
| Operating Income | -2 | -1,005 | -2,028 | -710 | -720 |
| Interest Expense | 0 | 353 | 791 | 196 | 53 |
| Other Income | 0 | -947 | -1,025 | 74 | -27 |
| Pre-tax Income | -2 | -2,305 | -3,845 | -832 | -801 |
| Income Tax | N/A | 1 | 1 | N/A | N/A |
| Net Income Continuous | -2 | -2,305 | -3,845 | -832 | -801 |
| Net Income Discontinuous | N/A | -315 | -406 | N/A | N/A |
| Net Income | $-2 | $-2,620 | $-4,251 | $-832 | $-801 |
| EPS Basic Total Ops | 0.00 | -238.81 | -537.31 | 0.00 | -477.61 |
| EPS Basic Continuous Ops | -0.12 | -238.81 | -477.61 | -115.01 | -487.40 |
| EPS Basic Discontinuous Ops | N/A | -28.90 | -59.70 | N/A | N/A |
| EPS Diluted Total Ops | 0.00 | -238.81 | -537.31 | 0.00 | -477.61 |
| EPS Diluted Continuous Ops | -0.12 | -238.81 | -477.61 | -115.01 | -487.40 |
| EPS Diluted Discontinuous Ops | N/A | -28.90 | -59.70 | N/A | N/A |
| EBITDA(a) | $-2 | $-403 | $-1,377 | $-527 | $-635 |